Medicinal Ingredient (per 1 capsule):
Chaga (Inonotus obliquus, mycelium)... 180 mg (20:1, QCE 3.6 g)

Non-Medicinal Ingredient:
Hypromellose (Vegetable Capsule Shell)
Microcrystalline cellulose

Recommended Dose:
Adults: 1 Capsule 1 time per day.

Cautions and Warnings:
Consult a health care practitioner prior to use if you are pregnant or breastfeeding.

Q: What are the Health Canada approved uses for this product?
A: This product is approved by Health Canada (NPN 80064004) for the following uses: source of antioxidants; and traditionally used in Herbal Medicine. This product is not intended to diagnose, treat, cure, or prevent any disease.

Q: The label says "3600mg" but the supplement facts show 180mg. Which is correct?
A: Both are correct — they refer to different things. The 180mg is the actual weight of chaga extract in each capsule. The 3,600mg refers to the QCE (Quantity of Crude Equivalent) — the amount of raw chaga mycelium that was used to produce the extract in each capsule. This product uses a 20:1 concentrated extract, meaning 20 grams of raw chaga mycelium were processed to produce 1 gram of extract. The math: 180mg extract × 20 = 3,600mg QCE. So each 180mg capsule delivers the concentrated bioactive compounds from 3,600mg of raw chaga mycelium. QCE is the Health Canada standardized notation for expressing raw material equivalents of concentrated herbal extracts, and it is the most meaningful measure of potency for a concentrated extract.

Q: What does 20:1 concentration ratio mean and why does it matter?
A: A 20:1 concentration ratio means that 20 grams of raw chaga mycelium were used to produce 1 gram of extract. This is achieved through an extraction process that concentrates the bioactive compounds from the raw material and removes inert material such as indigestible chitin — the structural polysaccharide of fungal cell walls. The result is a much smaller volume of material that contains the bioactive compounds from a much larger amount of raw chaga. A 20:1 extract is 5 times more concentrated per gram than a 4:1 extract, and 20 times more concentrated than raw dried chaga powder. The practical benefit is that a small 180mg capsule can deliver the equivalent bioactive content of 3,600mg of raw chaga — making it possible to achieve a high-potency dose in a single, easy-to-swallow capsule without requiring large capsule sizes or multiple capsules per serving.

Q: How does this compare to other chaga supplements that also claim "3600mg"?
A: This is an important question because "3600mg" on a chaga supplement label can mean very different things depending on the product. If a product states "3600mg" without specifying that it is a QCE of a concentrated extract, it may be referring to 3,600mg of raw dried chaga powder — which has a very different bioactive compound concentration than a 20:1 extract with a QCE of 3,600mg. Raw chaga powder at 3,600mg contains the bioactive compounds present in 3,600mg of raw chaga. A 20:1 extract with a QCE of 3,600mg contains those same bioactive compounds concentrated from 3,600mg of raw chaga into just 180mg of extract — a much smaller, more concentrated dose. When comparing chaga supplements, always check whether the stated milligram amount is the extract weight, the QCE, or raw powder, and what the concentration ratio is. This product clearly states both: 180mg extract (20:1), QCE 3.6g.

Q: What is QCE and why does Health Canada use it?
A: QCE stands for Quantity of Crude Equivalent. It is the Health Canada standardized notation for expressing the raw material equivalent of a concentrated herbal extract on a natural health product label. Health Canada requires QCE to be stated on NHP labels when a concentrated extract is used, so that consumers can understand how much raw plant or fungal material is represented by the extract dose. QCE provides a standardized basis for comparing the potency of different extract concentrations and allows consumers to understand the relationship between the extract dose and the raw material it was derived from. Without QCE, a label showing only "180mg" would not convey that this represents the equivalent of 3,600mg of raw chaga.

Q: Why is the capsule format the most convenient way to take chaga?
A: The capsule format eliminates all preparation requirements. Chaga tea grind requires 15 to 20 minutes of simmering and straining. Extract powder requires measuring and mixing into a beverage. Liquid tincture requires counting drops. The capsule requires none of these steps — one capsule per day with water, and the dose is complete. There is no taste (the extract is enclosed within a vegetable cellulose capsule shell), no measuring variability, no equipment, and no cleanup. Each capsule contains a precisely measured 180mg of 20:1 extract (QCE 3.6g), delivering the same dose every time. For individuals who want consistent, high-potency chaga supplementation with the simplest possible daily routine, the capsule format is the most straightforward option.

Q: How long does one bottle last and what is the daily dose?
A: The suggested use is 1 capsule per day for adults. At this dose, the 120-capsule bottle provides a 120-day supply — 4 months from a single bottle. This is one of the longest supply durations available in a single chaga supplement bottle and reduces the frequency of reordering for consistent daily users. Consult your healthcare provider to determine the appropriate dosage for your individual needs.

Q: What bioactive compounds does chaga contain and what makes it a source of antioxidants? A: Chaga's antioxidant profile comes from several distinct compound classes. The melanin complex — responsible for chaga's distinctive black exterior — is one of the richest natural concentrations of melanin found in any organism, produced as a protective response to UV radiation and oxidative stress. This melanin-polyphenol complex is a major contributor to chaga's antioxidant activity. Polysaccharides and beta-glucans are complex carbohydrates found in the fungal cell wall and are among the most studied bioactive compounds in medicinal fungi. Betulinic acid and betulin are triterpenoid compounds derived from the birch tree host, unique to birch-grown chaga. Inotodiol and lanosterol are lanostane-type triterpenoids characteristic of Inonotus obliquus. Polyphenols and flavonoids provide additional antioxidant activity. Together these compounds are the basis for Health Canada's approval of this product (NPN 80064004) as a source of antioxidants.

Q: What is the difference between chaga mycelium and the chaga sclerotium?
A: The sclerotium is the black external mass visible on birch trees — the part most people recognize as chaga. It is a hardened mass of fungal mycelium mixed with birch tree compounds and is the traditional source of chaga used in herbal medicine. The mycelium refers to the thread-like fungal network — the vegetative body of the fungus that grows through the wood of the birch tree. This formula uses Inonotus obliquus mycelium as the source material for the 20:1 extract. Both the sclerotium and mycelium contain chaga's characteristic bioactive compounds, though their relative concentrations may differ depending on the part used and the extraction method applied.

Q: Is this product suitable for vegans and vegetarians?
A: Yes, this chaga capsule supplement is 100% vegan and suitable for both vegans and vegetarians. Chaga is a fungus — entirely plant kingdom-derived with no animal products involved. The capsule shell is made from hypromellose (vegetable cellulose), not gelatin. The only non-medicinal ingredient besides hypromellose is microcrystalline cellulose, a plant-derived filler. The product is also non-GMO and free from gluten, soy, and dairy.

Q: Are there any safety considerations I should know about?
A: Consult a healthcare practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare professional before use if you are taking medications (particularly blood thinners such as warfarin, or medications for diabetes), or have a medical condition including autoimmune conditions or kidney disease. Two specific considerations are particularly important. First, chaga contains oxalates — naturally occurring compounds found in many plant and fungal foods. Individuals with a history of kidney stones, particularly calcium oxalate kidney stones, should consult a healthcare provider before use, as high oxalate intake may increase the risk of stone formation. Second, chaga may have mild anticoagulant (blood-thinning) properties. Individuals taking blood-thinning medications such as warfarin (Coumadin) should consult a healthcare provider before use. This product is not intended to diagnose, treat, cure, or prevent any disease.